The Use of Reconstructive Surgery for Sexually Mutilated Women at the University Hospitals of Strasbourg

NCT ID: NCT06183463

Last Updated: 2023-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

29 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-24

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite awareness since the 1980s and a legal framework to punish sexual mutilation, this tradition continues in many countries, particularly in Africa but not only in the Middle East, Malaysia and Indonesia. This custom, carried out among increasingly young little girls, exposes them to infectious, hemorrhagic and even death risks and sometimes significant obstetric complications.

Every year, 3 million girls and young women are sexually mutilated around the world, or one woman every 15 seconds.

In recent years, a surgical repair technique has been created by a French urologist, Professor Foldès. This technique allows clitoral reconstruction. Sensory reacquisition after this intervention may take a few months, but the functional results are quite good.

There is little or no data concerning the use of reconstructive surgery for these mutilated patients consulting in sexology and the future of patients post-operatively or who have not had recourse to reconstructive surgery. The investigators then questioned the decision of these patients and their future.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sexual Trauma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Sexual mutilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult woman (≥18 years old)
* having consulted sexology at the HUS for sexual mutilation between 01/01/2011 and 12/31/2021.
* having had clitoral repair surgery at the HUS between 01/01/2011 and 12/31/2021
* not objecting, after information, to the reuse of their data for the purposes of this research

Exclusion Criteria

* Woman who expressed her opposition to participating in the study
* impossibility of providing the subject with informed information (difficulties in understanding the subject, etc.)
* Woman under judicial protection or under guardianship or curatorship.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service d'Assistance Médicale à la Procréation - CHU de Strasbourg - France

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jeanine OHL, MD

Role: CONTACT

Phone: 33 3 69 55 34 49

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jeanine OHL, MD

Role: primary

Virginie TEISSEYRE, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8724

Identifier Type: -

Identifier Source: org_study_id